Sipuleucel-T refers to an adoptive cell transfer therapy for prostate cancer where a pt's dendritic cells are extracted and incubated with a protein that contains antigen prostatic acid phosphatase (PAP) which helps the dendritic cells mature. The activated cells are then re-infused into the pt. A complete Tx includes 3 infusions at 2-wk intervals.